Clinical Trial Update: S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct [Phase 2]

View source ↗

Summary

Phase 2 trial S0809 evaluated capecitabine and gemcitabine with radiation therapy in cholangiocarcinoma of the gallbladder or bile duct. The study is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-09-22